A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea.
Hee Jin ParkSung Jin KimKaterina Rok SongJing ShenJoon-Hyung KimRaghavendra DevadigaHee-Cheol KangPublished in: Journal of Korean medical science (2019)
ClinicalTrials.gov Identifier: NCT01929291.